Redo-surgery following curative resection of pancreatic carcinoma: The difference between true and suspected recurrence

Digestive Surgery

Volumn 26, Issue 3, 2009, Pages 222-228

  Seelig, Matthias H ^a   Janot, Monika ^a   Chromik, Ansgar M ^a   Herzog, Torsten ^a   Belyaev, Orlin ^a   Weyhe, Dirk ^c   Meurer, Kirsten ^a   Meiser, Andreas ^a   Tannapfel, Andrea ^b   Uhl, Waldemar ^a  

^a ST JOSEF HOSPITAL   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c PIUS HOSPITAL   (Germany)

Author keywords

Chronic pancreatitis; Re resection; Recurrent pancreatic cancer

Indexed keywords

ADULT; AGED; ARTICLE; BYPASS SURGERY; CANCER RECURRENCE; CANCER SURGERY; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; OVERALL SURVIVAL; PANCREAS CARCINOMA; PANCREATICOJEJUNOSTOMY; REOPERATION; SURGICAL MORTALITY; TREATMENT INDICATION; TUMOR BIOPSY;

ADULT; AGED; CARCINOMA; CLINICAL PROTOCOLS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; PANCREATICOJEJUNOSTOMY; PROSPECTIVE STUDIES; REOPERATION; TREATMENT OUTCOME;

EID: 66049116809     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000219332     Document Type: Article

References (15)

1. Lieberman MD, Kilburn H, Lindsey M, et al: Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg 19 95;222:638-645.
2. Tran KT, Smeenk HG, van Eijck CH, et al: Pylorus preserving pancreaticoduodenecto-my versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg 2004;240:738-745.
3. Seiler CA, Wagner M, Bachmann T, et al: Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection:long term results. Br J Surg 2005;92:547-556.
4. Belyaev O, Herzog T, Chromik A, et al: Surgery of the pancreas: the surgeon as the crucial prognostic factor. Gastroenterologe 2006;1:34-42.
5. Oettle H, Post S, Neuhaus P, et al: Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized control led trial. JAMA 2007;297:267-277.
6. Neoptolemos JP, Stocken DD, Friess H, et al: A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004;350:1200-1210.
7. Yeo CJ, Cameron JL, Lillemoe KD, et al: Pan-creaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortalit y. Ann Surg 20 02;236:355-366; discussion 366-368.
8. Smeenk HG, Incrocci L, Kazemier G, et al: Adjuvant 5-FU-based chemoradiotherapy for patients undergoing R-1/R-2 resections for pa ncreatic cancer. Dig Surg 2005;22:321-328.
9. Verbeke CS, Leitch D, Menon KV, et al: Redefining the R1 resection in pancreatic cancer. Br J Surg 2006;93:1232-1237.
10. Kleeff J, Reiser C, Hinz U, et al: Surgery for recurrent pancreatic ductal adenocarcino-ma. Ann Surg 2007;245:566-572.
11. Bassi C, Dervenis C, Butturini G, et al: Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005;138:8-13.
12. Traverso LW, Longmire WP Jr: Preservation of the pylorus in pancreaticoduodenectomy. Surg Gynecol Obstet 1978;146:959-962.
13. Traverso LW, Longmire WP Jr:Preservation of the pylorus in pancreaticoduodenectomy: a follow-up evaluation. Ann Surg 1980;192:306-310.
14. Hedberg M, Borgström A, Genell S, et al: Survival following pancreatic carcinoma: a follow-up study of all cases recorded in Malmö, Sweden, 1977-1991. Br J Surg 1998;85:1641-1644.
15. Adler G, Seufferlein T, Bischoff SC, et al: S3-Guidelines 'exocrine pancreatic cancer' 2007. Z Gastroenterol 2007;45:487-523.